Indication
Staphylococcal meningitis
Staphylococcal meningitis is an acute, severe bacterial infection of the central nervous system characterized by purulent inflammation of the leptomeninges and subarachnoid space caused by species of the genus *Staphylococcus*, most commonly *Staphylococcus aureus* or coagulase-negative staphylococci such as *Staphylococcus epidermidis*. Read more about Staphylococcal meningitis
115 drugs 52 manufacturers
Drugs that treat it
Common Staphylococcal meningitis therapies.
OXACILLIN SODIUM
NAFCILLIN SODIUM
OXACILLIN SODIUM
AMIKACIN SULFATE
AMIKACIN SULFATE
CEFTRIAXONE (ceftriaxone sodium)
AMIKACIN SULFATE
CEFTRIAXONE (ceftriaxone sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStaphylococcal meningitis is an acute, severe bacterial infection of the central nervous system characterized by purulent inflammation of the leptomeninges and subarachnoid space caused by species of the genus *Staphylococcus*, most commonly *Staphylococcus aureus* or coagulase-negative staphylococci such as *Staphylococcus epidermidis*.
It primarily affects neurosurgical patients, individuals with indwelling central nervous system devices—such as cerebrospinal fluid shunts or external ventricular drains—and patients experiencing hematogenous seeding secondary to staphylococcal bacteremia or endocarditis.
Clinically, the disease manifests with hallmark features of meningeal irritation, including fever, headache, altered mental status, and nuchal rigidity, accompanied by neutrophilic cerebrospinal fluid pleocytosis, elevated protein levels, and markedly reduced glucose.
- nih.gov
Staphylococcal meningitis is an acute, severe bacterial infection of the central nervous system characterized by purulent inflammation of the leptomeninges and subarachnoid space caused by species of the genus *Staphylococcus*, most commonly *Staphylococcus aureus* or coagulase-negative staphylococci such as *Staphylococcus epidermidis* It primarily affects neurosurgical patients, individuals with indwelling central nervous system devices—such as cerebrospinal fluid shunts or external ventricula...
- nih.gov
It primarily affects neurosurgical patients, individuals with indwelling central nervous system devices—such as cerebrospinal fluid shunts or external ventricular drains—and patients experiencing hematogenous seeding secondary to staphylococcal bacteremia or endocarditis
- nih.gov
Clinically, the disease manifests with hallmark features of meningeal irritation, including fever, headache, altered mental status, and nuchal rigidity, accompanied by neutrophilic cerebrospinal fluid pleocytosis, elevated protein levels, and markedly reduced glucose
- nih.gov
Clinically, the disease manifests with hallmark features of meningeal irritation, including fever, headache, altered mental status, and nuchal rigidity, accompanied by neutrophilic cerebrospinal fluid pleocytosis, elevated protein levels, and markedly reduced glucose
Personalize your experience
Follow Staphylococcal meningitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.